Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children
Sponsor: Bioithas SL
Summary
Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy paediatric population.
Official title: Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in a Healthy Paediatric Population
Key Details
Gender
All
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
268
Start Date
2024-12-17
Completion Date
2027-04
Last Updated
2025-09-12
Healthy Volunteers
Yes
Interventions
Probiotic - Lacticaseibacillus rhamnosus CRL1505
The probiotic product is provided in 2g sticks containing the strain Lacticaseibacillus rhamnosus CRL1505 at a concentration of ≥ 1.0E+8 CFU/g, with corn starch and maltodextrin as excipients.
Placebo
The placebo product is provided in 2g sticks of corn starch and maltodextrin.
Locations (1)
MiBioPath Research Group (UCAM)
Murcia, Spain